Chinese companies will be excluded from bidding on certain large-scale public contracts for medical devices in the European Union, the bloc’s executive arm announced on Friday.
The European Commission said the restriction applies to contracts valued over 5 million dollars (5.7 million dollars) and marks the first use of a 2022 EU regulation designed to counter discriminatory practices against European firms abroad.
The regulation allows the EU to impose penalties on countries that limit access for European companies in public procurements.
Officials in Brussels say the move is aimed at encouraging more reciprocal market conditions, particularly in China, where EU suppliers face steep barriers.
“This response is proportionate to China’s barriers, while ensuring that all the necessary medical devices are available for the EU healthcare system.
Exceptions will be in place where no alternative suppliers exist,” a commission statement said.
According to EU data, nearly 90 per cent of Chinese public tenders for medical devices disadvantage EU-made products and companies.
This is in spite of a surge in Chinese exports of such goods to the EU, which more than doubled between 2015 and 2023.
The restriction affects a wide range of medical products, including ventilators, X-ray machines, sterilisers, wheelchairs and dressings such as plasters.
The commission has been in dialogue with Beijing since 2024 but says discussions have failed to yield satisfactory outcomes. (NAN)
Stay ahead with the latest updates! Join The ConclaveNG on WhatsApp and Telegram for real-time news alerts, breaking stories, and exclusive content delivered straight to your phone. Don’t miss a headline — subscribe now!
